Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
NCT06674980
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of the study is to evaluate the efficacy of multiple human placental membrane products and Standard of Care (SOC) versus SOC alone in the management of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) over 12 weeks using a modified platform trial design.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Pathologic Processes
- Diabetes Mellitus
- Glucose Metabolism Disorders
- Metabolic Diseases
- Endocrine System Disease
- Diabetic Angiopathies
- Vascular Diseases
- Cardiovascular Diseases
- Leg Ulcer
- Skin Ulcer
- Skin Diseases
- Diabetes Complications
- Diabetic Neuropathies
- Foot Diseases
- Diabetic Foot
- Foot Ulcer
- Diabetes Mellitus, Type 2
- Ulcer
- Foot Ulcer Unhealed
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- C5 Biomedical
- Last updated on ClinicalTrials.gov
- December 27, 2024
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Louisiana · 1
- Poirot Podiatry · Metairie, LA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.